Skip to content

Potassium Ferrate Hemostatic Sealant-Assisted Early Radial Hemostasis After Transradial Coronary Angiography and PCI

Potassium Ferrate Hemostatic Sealant-Assisted Early Radial Hemostasis After Transradial Coronary Angiography and PCI. A Randomized, Single-centre, Superiority Trial at the Mazankowski Alberta Heart Institute Cardiac Catheterization Laboratory (Edmonton, Alberta, Canada)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07768839
Acronym
MAHI-SEAL-60
Enrollment
300
Registered
2026-08-17
Start date
2026-10-01
Completion date
2032-06-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Angiogram, Early Discharge Trans Radial Angiography

Keywords

Angiogram, Angioplasty, Radial angiogram, Potassium Ferrate Hemostatic Sealant (PFHS)

Brief summary

This study aims to evaluate patients undergoing coronary angiography by comparing the use of Potassium Ferrate Hemostatic Sealant (PFHS) in addition to the standard of care (SOC) pneumatic radial compression device versus SOC alone. The objective is to determine whether the addition of PFHS reduces the time to successful deflation and removal of the radial compression device.

Detailed description

Trans radial access is commonly used for coronary angiography and Percutaneous Coronary Intervention (PCI) because it lowers bleeding risk and allows faster recovery compared with femoral access. However, achieving safe hemostasis while keeping the radial artery open is important, as prolonged or excessive compression can lead to radial artery occlusion. At MAHI, hemostasis is currently managed with a pneumatic compression device and a 60-90 minute compression period before deflation. Reducing the time to safe device deflation and removal could improve patient comfort, reduce nursing workload, and support earlier discharge. This is particularly important in a centralized healthcare system like Alberta's, where many patients travel long distances for care and may benefit from shorter and more predictable recovery times.

Interventions

DEVICEExperimental: PFHS + pneumatic radial compression device

PFHS applied at arteriotomy + pneumatic radial compression device placement; deflation protocol starts at 20 minutes using the Stat Seal 2-step deflation method regardless of PCI procedure.

DEVICEPneumatic radial compression device alone.

Pneumatic radial compression device alone (no PFHS) + identical deflation protocol starts at 60 minutes for diagnostic procedures and 90 minutes for PCI procedures

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years • Undergoing trans radial coronary angiography with or without PCI * Radial 6Fr Prelude sheath used for the procedure * Planned use of Inflation band (Sunny Medical) radial compression device for hemostasis * Able to provide informed consent * Adequate collateral circulation per institutional radial access screening (consistent with device contraindications).

Exclusion criteria

* On a GPIIB/IIIA inhibitor * Known hypersensitivity to device materials * Infection or serious skin disease at puncture site * Abnormal collateral circulation test / insufficient dual arterial supply * Inability to complete study assessments before discharge * Conversion to femoral access or need for alternate hemostasis device * Prior radial artery harvest or known chronic radial artery occlusion in the study limb (per operator judgement).

Design outcomes

Primary

MeasureTime frameDescription
PFHS plus pneumatic radial compressionImmediately after the interventionPFHS plus pneumatic radial compression initiated at 20 minutes, compared with pneumatic radial compression alone.

Secondary

MeasureTime frameDescription
Time to patient discharge between trial armsImmediately after the interventionTime to patient discharge between trial arms.
Radial artery patency at discharge compared between both trial armsImmediately after the interventionPlethysmography and pulse oximetry with reverse Barbeau testing (A-D classification).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026